These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9794429

  • 1. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells.
    Hirasawa N, Sato Y, Fujita Y, Mue S, Ohuchi K.
    J Immunol; 1998 Nov 01; 161(9):4939-43. PubMed ID: 9794429
    [Abstract] [Full Text] [Related]

  • 2. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K, Shirasawa S, Nishioka M, Sasazuki T.
    Cancer Res; 1999 May 15; 59(10):2445-50. PubMed ID: 10344756
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM.
    J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
    Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L.
    J Invest Dermatol; 2003 Apr 15; 120(4):561-70. PubMed ID: 12648218
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase.
    Zohn IE, Yu H, Li X, Cox AD, Earp HS.
    Mol Cell Biol; 1995 Nov 15; 15(11):6160-8. PubMed ID: 7565768
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells.
    Hirasawa N, Sato Y, Fujita Y, Ohuchi K.
    Biochim Biophys Acta; 2000 Jan 03; 1456(1):45-55. PubMed ID: 10611455
    [Abstract] [Full Text] [Related]

  • 10. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells.
    Rider LG, Hirasawa N, Santini F, Beaven MA.
    J Immunol; 1996 Sep 15; 157(6):2374-80. PubMed ID: 8805635
    [Abstract] [Full Text] [Related]

  • 11. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
    Atfi A, Prunier C, Mazars A, Défachelles AS, Cayre Y, Gespach C, Bourgeade MF.
    Oncogene; 1999 Jul 01; 18(26):3878-85. PubMed ID: 10445851
    [Abstract] [Full Text] [Related]

  • 12. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.
    Kawakami Y, Hartman SE, Holland PM, Cooper JA, Kawakami T.
    J Immunol; 1998 Aug 15; 161(4):1795-802. PubMed ID: 9712046
    [Abstract] [Full Text] [Related]

  • 13. Inhibition by dexamethasone of interleukin 13 production via glucocorticoid receptor-mediated inhibition of c-Jun phosphorylation.
    Hirasawa N, Izumi S, Linwong W, Ohuchi K.
    FEBS Lett; 2003 Nov 20; 554(3):489-93. PubMed ID: 14623117
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures.
    Ventura JJ, Roncero C, Fabregat I, Benito M.
    Hepatology; 1999 Mar 20; 29(3):849-57. PubMed ID: 10051489
    [Abstract] [Full Text] [Related]

  • 15. RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.
    Standaert ML, Bandyopadhyay G, Antwi EK, Farese RV.
    Endocrinology; 1999 May 20; 140(5):2145-51. PubMed ID: 10218965
    [Abstract] [Full Text] [Related]

  • 16. Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
    Germack R, Dickenson JM.
    Br J Pharmacol; 2000 Jun 20; 130(4):867-74. PubMed ID: 10864894
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
    Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R.
    Mol Endocrinol; 1998 Jun 20; 12(6):815-24. PubMed ID: 9626657
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of 46 and 54 kDa jun N-terminal kinases and p38 mitogen-activated protein kinase by human alpha(1A)-adrenoceptors expressed in Rat-1 cells.
    Alexandrov A, Keffel S, Goepel M, Michel MC.
    Biochem Biophys Res Commun; 1999 Aug 02; 261(2):372-6. PubMed ID: 10425192
    [Abstract] [Full Text] [Related]

  • 19. Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide.
    Nogueira TC, Graciano MF, Anhê GF, Curi R, Bordin S, Carpinelli AR.
    Pancreas; 2009 Jul 02; 38(5):585-92. PubMed ID: 19295452
    [Abstract] [Full Text] [Related]

  • 20. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells.
    Rizzo MT, Carlo-Stella C.
    Blood; 1996 Nov 15; 88(10):3792-800. PubMed ID: 8916943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.